5372 Sravanthi et al.
Asian J. Chem.
m.p. 107-111 ºC; IR (KBr, νmax, cm-1) 3051, 2955, 1965, 1905,
1307, 1246, 751, 711; 1H NMR δ 7.56-7.70 (m, 10H, Ar-H),
7.85-8.01 (m, 8H, Ar-H), 6.99-7.42(m, 8H,Ar-H), 4.52(s, 2H,
CH2), 5.76(s, 2H, -CH-S in thiazolidene ring), 3.30 (s, 3H,
-O-CH3); m/z 728.
corresponding bisthiazolidenes were obtained. The mass
spectra and the proton NMR values were in agreement with
the expected products (3ii-3v). The yields and the reaction
times were compared and found the better results in non-
conventional method.
Conclusion
RESULTS AND DISCUSSION
We designed and synthesized the hitherto unreported 4,4'-
[N,N'-bis(3-phenyl-4-(4-substituted phenyl)-thiazol-2(3H)-
ylidene)]methylenedianiline derivatives in good yields by non-
conventional method using ultrasonication and moderate yield
by conventional method. This methodology has been confir-
med by the synthesis of various bisthiazolidene derivatives.
Reaction of compound bearing amino group with phenyl
isothiocyanate in presence of ethanol gives the corresponding
disubstituted thiourea14. Similarly, 4,4'-diaminodiphenyl-
methane (1) on treatment with twice the molar weight of phenyl
isothiocyanate gives the corresponding disubstituted bis thio-
urea compound (2). The disubstituted bis thiourea product
formed was collected by evaporating the solvent under reduced
pressure. The formation of bis thiourea was confirmed by IR
spectrum which showed the characterization bands at 3316
cm-1 represents the N-H stretching, the band at 1591 cm-1
represents aromatic C=C and the band at 1490 cm-1 represents
aromatic C=S. Then, the proton NMR peaks and intense
molecular ion peak at 468 in mass spectrum are also in agree-
ment with the structure of the bis thiourea compound (2).
Further, the bisthiourea (2) on treating with phenacylbromide
(prepared by treating 5 mmol of acetophenone with mixture
of potassium bromide and potassium bromate (2:1, 1 g, 5 mmol
available bromine) in the presence 1 N hydrochloric acid) in
presence of catalytic amount of iodine undergoes Hantzsch
thiazole condensation followed by E1 elimination gives corres-
ponding bisthiazolidene product (3i)15. The formation of the
bisthiazolidene product was confirmed from mass spectrum
which showed the m/z values 671. Then, the proton NMR
values was also in agreement with the 4,4'-(N,N'-bis(3,4-diphe-
nyl-thiazol-2-ylidene))methylenedianiline product (3i). To
carry out the reaction in shorter time and in convenient method,
the ethanol solution of bisthiourea (2) was treated with aceto-
phenone in presence of iodine as the reagent and allowed to
reflux the reaction mixture for 2 h. We found that the time for
completion of the reaction was reduced and yield compara-
tively higher than in the above method. Further, we carried
out the heterocyclization by non-conventional method using
ultrasonication, the reaction was found to be completed within
22 min. We finally concluded that the reaction was easily
carried out in ultrasonication method with good yield and shortest
time period. Both the conventional and non-conventional
methods were followed to carry out the heterocyclization of
bisthiourea (2) with various substituted acetophenones, the
ACKNOWLEDGEMENTS
The authors thank VIT University, Vellore for financial
support and FTIR spectra, Mr. Kiran Desai and Ms. Mini
Dhiman for NMR spectra and mass spectra.
REFERENCES
1. A.K. Sanguptha, V.R. Rajeshwar and V.T.R. Padmaja, Collect. Czech.
Chem. Commun., 55, 535 (1990).
2
3
4
K. Brown, D.P. Cater, J.F. Cavalla, D. Green, R.A. Newberry and A.B.
Wilson, J. Med. Chem., 14, 1177 (1994).
D.F. Shi, T.D. Bradshaw, M.S. Chua,A.D. Weatwell and M.F.G. Stevens,
Bioorg. Med. Chem. Lett., 11, 1093 (2001).
E. Kashiyama, I. Hutchinson, M.S. Chua, S.F. Stinson, L.R. Philips,
G. Kaur, E.A. Sauville, T.D. Bradshaw, A.D. Westwell and M.G.
Stevens, J. Med. Chem., 42, 4172 (1999).
5
6
7
D. Wright and L. Usher, Curr. Org. Chem., 5, 1107 (2001).
A. Naock,A. Schroder and H. Hartmann, Dye Pigments, 57, 131 (2002).
Y. Martin-Cantalejo, B. Saez, J. Soto, M.J. Villa and M.F. Brana, Syn-
thesis, 2211 (2003).
8
9
A. Badroc, M.F. Bordes, P. De cointet, P. Savi, A. Bernat, A. Lale, M.
Petitou, J.P. Maffrand and J.M. Herberrt, J. Med. Chem., 40, 3393 (1997).
J. Rudolph, H. Theis, R. HAnke, R. Endermann, L. Johannsen and
F.U. Geshka, J. Med. Chem., 44, 619 (2001).
10 S. Bae, H.G. Hahn, K.D. Nam and H.J. Mah, J. Comb. Chem., 7, 7 (2005).
11 D.S. Kim, Y.M. Joeng, I.K. Park, H.G. Hahn, H. K. Lee, S.B. Kwon,
J.H. Joeng, S.J. Yang, U.D. Sohn and K.C. Park, Biol. Pharm. Bull.,
20, 180 (2007).
12 F. Nagasaki, T. Yamada, E. Taksahashi, Y. Kitawaga, R. Hatano and
Kokai Tokkyo Koho, Chem. Abstr., 110, 192810 (1989).
13 N. Siddiqui and W. Asham, Eur. J. Med. Chem., 45, 1536 (2009).
14 B. Hegazi, H.A. Mohamed, K.M. Dawood and F.Abdek-Rahem Badria,
Chem. Pharm. Bull., 58, 479 (2010).
15 S. Murru, C.B. Singh, V. Kavala and B.K. Patel, Tetrahedron, 64, 1931
(2008).